Drug Profile
Research programme: biotherapeutic antibodies - Sea Lane Biotechnologies
Alternative Names: Avian influenza virus antibodies - Sea Lane BiotechnologiesLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Sea Lane Biotechnologies LLC
- Developer Sea Lane Biotechnologies
- Class Antibodies; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Influenza A virus H5N1 subtype; Influenza virus infections; Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-A-virus-H5N1-subtype in USA (Parenteral)
- 16 Jul 2016 No recent reports of development identified for research development in Influenza-virus-infections in USA (Parenteral)